Study Stopped
PI leaving the NIH
Loss of Depotentiation in Focal Dystonia
2 other identifiers
observational
6
1 country
1
Brief Summary
Background Focal dystonia is a brain disorder. It affects a muscle or muscles in a specific part of the body. Researchers think it may be related to excessive training or practice. They want to know more about how much training might trigger focal dystonia. Objectives: To study why people develop focal dystonia. To study how brain plasticity changes with focal dystonia. Eligibility: People at least 18 years of age with focal dystonia. Healthy volunteers the same age are also needed. Design: Participants will be screened with a physical exam and questions. They may have blood and urine tests. Participants will have up to 3 testing visits. Participants will have small electrodes stuck on the skin on the hands or arms. Muscle activity will be recorded. Participants will have transcranial magnetic stimulation (TMS). A wire coil will be placed onto the scalp. A brief electrical current will pass through the coil. The current will create a magnetic field that affects brain activity. Participants may be asked to tense certain muscles or do simple actions during TMS. A nerve at the wrist will get weak electrical stimulation. The stimulation may be paired with TMS for very short times. Participants will receive repeated magnetic pulses. Participants will receive a total of 150 pulses during a 10-second period. An entire testing visit will last about 3 hours. ...
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Start
First participant enrolled
September 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2020
CompletedMay 6, 2020
April 1, 2020
2.6 years
June 30, 2017
May 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MEP amplitude immediately after the PAS25-cTBS150 (depotentiation) protocol
compare MEP amplitude in patients with that in healthy volunteers to identify whether depotentiation is weaker in focal dystonia
throughout
Secondary Outcomes (1)
MEP amplitudes
throughout
Study Arms (2)
Focal Dystonia
Subjects diagnosed with Focal Dystonia
Healthy Volunteers
Healthy Volunteers
Interventions
We will record surface electromyography from the target abductor pollicis brevis muscle and adjacent first dorsal interosseous and abductor digiti minimi muscles.
We will record surface electromyography from the target abductor pollicis brevis muscle and adjacent first dorsal interosseous and abductor digiti minimi muscles. TBS is a special form of
We will record surface electromyography from the target abductor pollicis brevis muscle and adjacent first dorsal interosseous and abductor digiti minimi muscles.
Eligibility Criteria
Subjects (patients and healthy volunteers) are recruited through the NIH Patient Recruitment and Public Liaison Office and from individuals who have participated in prior studies and are interested in being contacted for additional studies. Additionally, individuals who have contacted NIH to volunteer for research studies will be considered for recruitment.
You may qualify if:
- At least 18 years old.\*
- Able to give informed consent.
- Able to comply with all study procedures.
- Abstain from alcohol for at least 48 hours prior to each study visit and caffeine on the day of the visit.
- Have no neurological or psychiatric disorders established by history and physical/neurological examination.
- = A maximum of 10 subjects who are over the age of 70 will be screened for plasticity. If none of these subjects have plasticity, we will not accrue any more subjects over the age of 70.
- At least 18-years old.\*
- Able to give informed consent.
- Able to comply with all study procedures.
- Abstain from alcohol for at least 48 hours prior to each visit of the study and caffeine on the day of the visit.
- Have an established diagnosis of focal dystonia.
- No botulinum toxin injections at least in the past 3 months.
- = A maximum of 10 subjects who are over the age of 70 will be screened for plasticity. If none of these subjects have plasticity, we will not accrue any more subjects over the age of 70.
You may not qualify if:
- Self-reported consumption of \> 14 alcoholic drinks/week for a man and \> 7 alcoholic drinks/week for a woman.
- Focal dystonia patients: presence of abnormal findings on neurological examination except for the diagnosis of focal dystonia. Healthy volunteers: no abnormal findings on neurological examination.
- History of or current brain tumor, stroke, head trauma with loss of consciousness, epilepsy or seizures.
- Have a Baclofen pump, or have neurostimulators for pain.
- Pregnant or breastfeeding women.
- Current episode of major depression or any major psychiatric illness.
- Presence of any metal in the eye or skull area such as a brain stimulator, shrapnel, surgical metal, clips in the brain, cochlear implants, metal fragments in the eye.
- Presence of pacemaker, intracardiac lines, implanted pumps or stimulators.
- Known hearing loss.
- Cognitive impairment.
- NIH staff from HMCS.
- Healthy Volunteers:
- Taking medications that act directly on the central nervous system such as anti- epileptics, anti-histamines, anti-parkinsonian medication, medication for insomnia, anti-depressants, anti-anxiety medication.
- Focal Dystonia Patients:
- Taking medications that act directly on the central nervous system such as anti- epileptics, anti-parkinsonian medication, medication for insomnia.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 2, 2017
Study Start
September 20, 2017
Primary Completion
April 9, 2020
Study Completion
April 9, 2020
Last Updated
May 6, 2020
Record last verified: 2020-04